Sitting Tai Chi Program Benefits Subacute Stroke Survivors

THURSDAY, April 7, 2022 (HealthDay News) -- A tailored 12-week sitting tai chi program is beneficial for the recovery of subacute stroke survivors, according to a study published online April 7 in Stroke.
Jie Zhao, Ph.D., from the Yunnan University of Traditional Chinese Medicine in Kunming, and colleagues conducted a 12-week randomized controlled trial in China involving subacute stroke survivor-caregiver dyads. Eighty dyads were randomly assigned to the sitting tai chi group and 80 to an attention control group.
The researchers found that the sitting tai chi group (69 participants) showed significant upper-limb function improvement in the primary outcomes, including performance time and functional ability domains of the Wolf Motor Function test, balance control, and sitting balance control immediately postintervention. Improvements were also observed in secondary outcomes, including depressive symptoms, shoulder extension, activities of daily living, and quality of life compared with the control group (65 participants).
"Sitting tai chi uses minimal resources with assurance of safety and could meet the transitional care needs of stroke survivors," the authors write. "The current program, the inpatient training combined with video-guided self-practice, was beneficial to provide subacute stroke survivors and their caregivers with the knowledge and ability to exercise during their hospitalization to facilitate the continuation of their recovery after their return to the community."
Related Posts
El ejercicio más dormir bien son la mejor combinación para el cerebro que envejece
VIERNES, 7 de julio de 2023 (HealthDay News) -- Hacer ejercicio con regularidad...
Los secretos biológicos de la mujer que no puede sentir dolor
MIÉRCOLES, 24 de mayo de 2023 (HealthDay News) -- Una combinación genética única...
Ruxolitinib Cream Results in Greater Repigmentation in Vitiligo
THURSDAY, Oct. 20, 2022 (HealthDay News) -- For patients with vitiligo,...
AE Risk Examined for Abiraterone, Enzalutamide in Prostate Cancer
MONDAY, June 6, 2022 (HealthDay News) -- For men with advanced prostate cancer,...